Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-11

Clinical Trial Update: Clopidogrel and Response Variability Investigation Study 2 [Phase 3]

View source ↗

Summary

Phase 3 trial update of clopidogrel in coronary artery disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOPIDOGREL (CLOPIDOGREL)
  • Plavix (clopidogrel)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED